Abstract:Mesenchymal stem cells (MSCs; also referred to as mesenchymal stromal cells) have attracted much attention for their ability to regulate inflammatory processes. Their therapeutic potential is currently being investigated in various degenerative and inflammatory disorders such as Crohn’s disease, graft-versus-host disease, diabetic nephropathy and organ fibrosis. The mechanisms by which MSCs exert their therapeutic effects are multifaceted, but in general, these cells are thought to enable damaged tissues to form a balanced inflammatory and regenerative microenvironment in the presence of vigorous inflammation. Studies over the past few years have demonstrated that when exposed to an inflammatory environment, MSCs can orchestrate local and systemic innate and adaptive immune responses through the release of various mediators, including immunosuppressive molecules, growth factors, exosomes, chemokines, complement components and various metabolites. Interestingly, even nonviable MSCs can exert beneficial effects, with apoptotic MSCs showing immunosuppressive functions in vivo. Because the immunomodulatory capabilities of MSCs are not constitutive but rather are licensed by inflammatory cytokines, the net outcomes of MSC activation might vary depending on the levels and the types of inflammation within the residing tissues. Here, we review current understanding of the immunomodulatory mechanisms of MSCs and the issues related to their therapeutic applications.

The role of mesenchymal stem cell-derived exosome in epigenetic modifications in inflammatory diseases

Mesenchymal Stem Cells and Their Exosomes: Promising Therapeutics for Chronic Pain

The Application of Mesenchymal Stem Cells and Their Exosomes in Chronic Pain Animals and Patients: A Brief Review.

Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics

Therapeutic Prospects of Mesenchymal Stem Cell and Their Derived Exosomes in the Regulation of the Gut Microbiota in Inflammatory Bowel Disease

The role of mesenchymal stem cells in attenuating inflammatory bowel disease through ubiquitination

Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases

The effects of mesenchymal stem cells-derived exosomes in rheumatoid arthritis: a review

Mesenchymal Stem Cell-derived Exosomes: Novel Therapeutic Approach for Inflammatory Bowel Diseases

Therapeutic potential of mesenchymal stem cell-derived exosomes in skeletal diseases

Systematic Exposition of Mesenchymal Stem Cell for Inflammatory Bowel Disease and Its Associated Colorectal Cancer

Enhancement of the therapeutic efficacy of mesenchymal stem cell-derived exosomes in osteoarthritis

Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes

[Research progress of mesenchymal stem cell-derived exosomes in the treatment of inflammatory bowel disease].

The Role of Amino Acid Metabolism in Inflammatory Bowel Disease and Other Inflammatory Diseases

Multifunctional role of microRNAs in mesenchymal stem cell-derived exosomes in treatment of diseases

Research progress of engineered mesenchymal stem cells and their derived exosomes and their application in autoimmune/inflammatory diseases

Therapeutic potential of exosome-based personalized delivery platform in chronic inflammatory diseases

Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism.

Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases

Role of mesenchymal stem cell-derived exosomes in the regeneration of different tissues